| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.6 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.6 |